Local Radiation Treatment of HER2-Positive Breast Cancer Using Trastuzumab-Modified Gold Nanoparticles Labeled with 177Lu

Depot system for controlled release of gold nanoparticles with precise intratumoral placement by permanent brachytherapy seed implantation (PSI) techniques

(2016) Priscilla Lai et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Intratumorally Injected 177Lu-Labeled Gold Nanoparticles: Gold Nanoseed Brachytherapy with Application for Neoadjuvant Treatment of Locally Advanced Breast Cancer

(2016) S. Yook et al.   JOURNAL OF NUCLEAR MEDICINE

Radiation Nanomedicine for EGFR-Positive Breast Cancer: Panitumumab-Modified Gold Nanoparticles Complexed to the β-Particle-Emitter, 177Lu

(2015) Simmyung Yook et al.   MOLECULAR PHARMACEUTICS

Bioorthogonal, two-component delivery systems based on antibody and drug-loaded nanocarriers for enhanced internalization of nanotherapeutics

(2013) Sudath Hapuarachchige et al.   BIOMATERIALS

Molecular Targeting Radiotherapy with Cyclo-RGDfK(C) Peptides Conjugated to 177Lu-Labeled Gold Nanoparticles in Tumor-Bearing Mice

(2013) Andrea Vilchis-Juárez et al.   Journal of Biomedical Nanotechnology

Definition and consequences of locally advanced breast cancer

(2013) Demetrios Simos et al.   Current Opinion in Supportive and Palliative Care

Molecularly targeted gold nanoparticles enhance the radiation response of breast cancer cells and tumor xenografts to X-radiation

(2012) Niladri Chattopadhyay et al.   BREAST CANCER RESEARCH AND TREATMENT

Laminin receptor specific therapeutic gold nanoparticles (198AuNP-EGCg) show efficacy in treating prostate cancer

(2012) R. Shukla et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Impact of Breast Cancer Molecular Subtypes on Locoregional Recurrence in Patients Treated with Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer

(2011) Michael O. Meyers et al.   ANNALS OF SURGICAL ONCOLOGY

Surgery following neoadjuvant therapy in patients with HER2-positive locally advanced or inflammatory breast cancer participating in the NeOAdjuvant Herceptin (NOAH) study

(2011) V. Semiglazov et al.   EJSO

Optimized digital counting colonies of clonogenic assays using ImageJ software and customized macros: Comparison with manual counting

(2011) Zhongli Cai et al.   INTERNATIONAL JOURNAL OF RADIATION BIOLOGY

Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials

(2011)   LANCET

Doses to internal organs for various breast radiation techniques - implications on the risk of secondary cancers and cardiomyopathy

(2011) Jean-Philippe Pignol et al.   Radiation Oncology

Preoperative concurrent paclitaxel-radiation in locally advanced breast cancer: pathologic response correlates with five-year overall survival

(2010) Sylvia Adams et al.   BREAST CANCER RESEARCH AND TREATMENT

Epidermal Growth Factor Receptor in Triple-Negative and Basal-Like Breast Cancer

(2010) Monika L. Burness et al.   CANCER JOURNAL

Computational analysis of the number, area and density of γ-H2AX foci in breast cancer cells exposed to111In-DTPA-hEGF or γ-rays using Image-J software

(2009) Zhongli Cai et al.   INTERNATIONAL JOURNAL OF RADIATION BIOLOGY

Associations between the uptake of 111In-DTPA-trastuzumab, HER2 density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts

(2008) Kristin McLarty et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Nanoparticle-mediated cellular response is size-dependent

(2008) Wen Jiang et al.   Nature Nanotechnology